News Daily News Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure L.A. McKeown May 31, 2017
News Daily News Post-MI High-Intensity Statin Use Has Doubled in Recent Years Michael O'Riordan May 30, 2017
News Conference News EuroPCR 2017 Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate Caitlin E. Cox May 22, 2017
News Conference News EuroPCR 2017 DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit Michael O'Riordan May 16, 2017
News Conference News EuroPCR 2017 TOPIC: Replacing P2Y12 Inhibitors With Clopidogrel 1 Month After PCI Saves Money, Prevents Bleeding in ACS Yael L. Maxwell May 16, 2017
News Daily News $2 Billion Annual Price Tag for FOURIER-Eligible VA Patients on PCSK9 Inhibitor Michael O'Riordan May 12, 2017
News Daily News Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women Todd Neale May 11, 2017
News Daily News More Excess Bleeding and No Benefit With Triple Therapy After PCI, Meta-analysis Finds Todd Neale May 05, 2017
News Daily News Extended DAPT May Benefit Patients With CAD and PAD, but With Caveats L.A. McKeown May 03, 2017
News Daily News ‘Forgotten’ Patients With Mechanical Heart Valves Undergoing PCI Pose Clinical Conundrum Todd Neale April 27, 2017
News Daily News One in Five Acute MI Patients Drop Statins Within 2 Years Michael O'Riordan April 20, 2017
News Daily News Absorb Comparable to Xience in Economic Analysis, but BVS Safety Concerns Could Alter Balance Michael O'Riordan April 18, 2017
News Daily News Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial Michael O'Riordan March 29, 2017
News Conference News ACC 2017 VISION: High-Sensitivity Troponin Strongly Linked to Increased Death From Myocardial Injury After Noncardiac Surgery L.A. McKeown March 19, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 FOURIER: Evolocumab Reduces Risk of CVD Events by 15% Compared With Placebo Michael O'Riordan March 17, 2017
News Conference News ACC 2017 Low HDL Cholesterol Common in Young MI Patients, With Young Women Faring Worse Long-Term Michael O'Riordan March 10, 2017
News Daily News The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score Todd Neale March 10, 2017